Pan-cancer analysis of m5C regulator genes reveals consistent epigenetic landscape changes in multiple cancers

Yuting He1,2,3,4, Xiao Yu5,6,7,8, Menggang Zhang5,6,7,8

  • 1Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, No.1 Jianshe Road, Zhengzhou, 450052, China. fccheyt1@zzu.edu.cn.

Abstract

Insights

Mutations in 5-methylcytosine (m5C) regulators are linked to cancer development and poor patient outcomes. Understanding these m5C alterations is crucial for cancer research.

Area of Science:

  • Epigenetics and Cancer Biology
  • RNA and DNA Modifications

Background:

  • 5-Methylcytosine (m5C) is a critical reversible epigenetic modification in DNA and RNA.
  • The role of m5C modifications and their regulators in human cancer remains largely undefined.
  • Understanding m5C dysregulation is essential for cancer pathogenesis and progression insights.

Purpose of the Study:

  • To investigate the correlation between m5C regulatory gene alterations and cancer development.
  • To assess the impact of m5C regulator expression on cancer hallmark pathways.
  • To determine the clinical significance of m5C regulator alterations in human tumors.

Main Methods:

  • Utilized The Cancer Genome Atlas (TCGA) database for comprehensive analysis.
  • Analyzed mutations and copy number variations (CNVs) in m5C regulatory genes across diverse cancer types.
  • Correlated m5C regulator expression with the activity of cancer hallmark pathways.

Main Results:

  • Identified significant correlations between m5C gene mutations/CNVs and various cancer types.
  • Observed upregulation of m5C regulators in tumor-specific processes, linking them to cancer progression.
  • Demonstrated that aberrant alterations in m5C regulatory genes are associated with poor clinical outcomes in multiple cancers.

Conclusions:

  • Provided strong evidence for the involvement of m5C regulators in cancer pathogenesis and survival.
  • Highlighted the clinical implications of m5C regulator alterations, suggesting their potential as biomarkers or therapeutic targets.

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.3K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.7K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.3K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.3K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K